Metyrosine

FDA Approved: * July 24, 2020
Pharm Company: * AMNEAL
Category: Cancer

Metirosine (INN and BAN; α-Methyltyrosine, Metyrosine USAN, AMPT) is an antihypertensive drug. It inhibits the enzyme tyrosine hydroxylase and, therefore, catecholamine synthesis, which, as a consequence, depletes the levels of the catecholamines dopamine, adrenaline and noradrenaline in the body. It is available as a generic medication.[1] Contents 1 Clinical use 2 See also 3 References 4 External links Clinical use Metirosine has been shown to suppress catecholam... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Metyrosine 250 mg Oral Capsule
NDC: 60219-1621
Labeler:
Amneal Pharmaceuticals Ny LLC
Metyrosine 250 mg Oral Capsule
NDC: 68682-310
Labeler:
Oceanside Pharmaceuticals
Metyrosine 250 mg Oral Capsule
NDC: 69238-1621
Labeler:
Amneal Pharmaceuticals Ny LLC

Related Brands

Drugs with the same active ingredients